Top Stories

The 4 Pillars of Your Next Career Choice

By Joseph Mullings     On my way back and it been a great 36 hours. London, Boston and Miami….great stuff and spending time with phenomenal clients and some fantastic individuals in the work place. We had some deep conversations about “next moves”. Whether you [...]

CEO Conversations

Visit The Mullings Group YouTube Channel to see our first edition in the CEO Conversations series featuring Rick Geoffrion, CEO of Mitralign and Joe Mullings, CEO of The Mullings Group                                 [...]

Med-Tech Startups – Doing the Hard Things

By Joseph Mullings     A good part of our business is working with emerging technology/ startup companies. It is really one of the most enjoyable parts of my work. Working with individuals and teams who have a clear passion for being in an environment [...]

International News

Cardiac Dimensions® Initiates European Commercialization of CARILLON® Mitral Contour System®

Commercial Rollout includes PRIME Study, Collecting Data on up to 300 European Patients KIRKLAND, Wash., Sept. 28, 2012 — /PRNewswire/ --Cardiac Dimensions®,Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON® Mitral Contour System® under its [...]

$265 million for Israeli-founded medical device company

An admirable exit for the Israeli-founded medical device company, Rhythmia Medical, as it gets picked up by Boston Scientific – a worldwide developer, manufacturer and marketer of medical devices- for $265 million. The agreement (signed today) calls for an upfront payment of $90 million payable [...]

Implant scandal sparks revamp of EU medical device rules

*Rules to tighten product approvals, safety checks * Changes follow French breast implant safety scandal * Plans must be approved by EU governments, lawmakers BRUSSELS, Sept 26 (Reuters) - The European Union has proposed tougher rules on assessing the safety and monitoring the use of [...]

European regulators approve Surefire Infusion System for chemo – and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately. "Surefire Medical developed this ground-breaking technology to provide interventional [...]